Morning routine
Apply a generous layer to clean skin. Wait one minute. Reapply every two hours when exposed to sun.
§I · FormulationFrom BIOSAR's Sensimed range
Soothing Light Cream SPF30
Sensimed Soothing Light Cream SPF30 is BIOSAR's daily protective moisturizer for sensitive and reactive skin. Azelaic Acid evens the look of redness and uneven tone; Niacinamide strengthens the barrier; broad-spectrum SPF30 filters help shield against UVA and UVB exposure. Use it every morning as the final step before makeup. The texture is fluid, fragrance-light, and disappears into skin without a white cast on most complexions. Tolerance-tested under dermatological supervision; suitable for skin prone to flushing or post-active recovery.
- CalendulaCalendula Officinalis Flower Oil (and separately Calendula Officinalis Flower Extract)
- Azelaic Acid
- Niacinamide
- PanthenolPanthenol (Provitamin B5)
Ten ranges
One philosophy
SFDA
Registered
GMP · ISO 22716
Standard
Why it works
One cream that calms, protects and evens tone all day. Calendula Oil and Azelaic Acid visibly reduce the look of redness and uneven tone while Niacinamide, Jojoba Oil, Vitamin E, Panthenol and Shea Butter flood skin with barrier-supporting comfort — all shielded by SPF30. Expect calmer, more even, protected skin, with visible calming in as little as 1 week.
- Calendula
- Azelaic Acid
- Niacinamide
- Panthenol
- Shea Butter
- Vitamin E
Proven Benefits
What this product does for your skin
Evens redness look
Azelaic Acid evens the look of redness and uneven tone.
Fluid, no white cast
The fragrance-light fluid disappears into skin without a white cast.
SPF30 defense
Broad-spectrum SPF30 filters help shield against UVA and UVB.
How the actives work together
Even-toned calm through the day, with the sun kept safely at bay
Azelaic Acid does the deeper work here, refining tone and helping quiet visible redness across the day. It is the demanding note, so Calendula Oil, Panthenol and Shea Butter surround it with soothing, barrier-caring softness, while Jojoba Oil, Niacinamide and Vitamin E round out the comfort. SPF30 seals the routine, so one light cream evens, calms and shields in a single morning step.
Ingredient Research
Active ingredients backed by published studies
- −35%
Calmed skin under radiation stress in a trial
In a 254-patient Phase III trial, calendula lowered grade-2-or-higher skin inflammation from 63% to 41% versus the comparator — a 35% relative drop — with significantly less radiation-induced pain reported.
J Clin Oncol 2004 (Pommier) — View research → - 65%
Most patients saw good-to-excellent melasma fading
In a 24-week double-blind trial, 20% azelaic acid delivered good or excellent results in 65% of patients with melasma, matching prescription 4% hydroquinone. No serious side effects such as ochronosis were seen.
Int J Dermatol 1991 — View research →
Transparency
What's inside — and what's not
Application Guide
How to use
Evening routine
Not recommended in the evening; use a Sensimed night cream instead.
Realistic Expectations
What to expect
I
Day 1
Comfort from first use
Redness-prone skin feels calmed and cushioned from the very first use — no sting, no tightness.
II
Week 1
Redness settles
Visible redness and reactivity look noticeably reduced as the barrier is soothed and supported.
III
Week 4–6
Calm, resilient skin
Complete Care
Build your Sensimed routine
You are here
Complete the routine
Pairs beautifully with
Frequently asked questions
Is the SPF30 in the Sensimed Soothing Cream enough for sensitive skin?
SPF30 provides adequate daily protection for most sensitive skin. For extended sun exposure, layer the Sunprotex Dry/Sensitive formula. Reapply every two hours outdoors.
Last reviewed by BIOSAR Scientific Team, PharmD, Cosmetic Chemistry, Pharmacy practice on .
Claims & methodology
- Soothes redness and protects against UV exposure — Tested for tolerance under dermatological supervision. Tolerance dossier on file at BIOSAR Laboratories.
Published references
- J Clin Oncol 2004 (Pommier). pubmed.ncbi.nlm.nih.gov/15084618/
- Int J Dermatol 1991. pubmed.ncbi.nlm.nih.gov/1816137/
- Dermatol Res Pract 2011 (Navarrete-Solís). pmc.ncbi.nlm.nih.gov/articles/PMC3142702/
